play_arrow

keyboard_arrow_right

skip_previous play_arrow skip_next
00:00 00:00
chevron_left
volume_up
chevron_left
  • cover play_arrow

    Rother Radio (128k) Love Local, Love Music!

  • cover play_arrow

    Rother Radio (64K) Love Local, Love Music!

  • cover play_arrow

    Hit Music Radio (128K) More Music Variety!

  • cover play_arrow

    Hit Music Radio (64K) The Best Variety of Hits!

Business News

GSK to build £400m hub in Stevenage – creating 5,000 jobs

today16/07/2021

Background
share close

Pharmaceutical giant GSK plans to create 5,000 jobs when it opens a new £400m UK hub in Stevenage, with work expected to begin in 2022.

The company is planning to develop a cluster of biotech firms, raising money for the project by selling land in Hertfordshire before developing it into one of the largest science campuses in the country.

It follows AstraZeneca’s announcement of its new £1bn global headquarters and research centre in Cambridge.

After receiving the backing of the UK government, the project is to commence in 2022. GSK is currently searching for a development partner through which it can sell 13.3 hectares of its plot in Stevenage, with hopes to raise £400m in private investment from the sale.

With the money, GSK said it would transform a third of its existing 37-hectare (92 acre) site to offer a potential 2.5m sq ft of space, depending on planning permission.

GSK's HQ is in Brentford in west London
Image: GSK’s current HQ in Brentford, west London

“Our goal is for Stevenage to emerge as a top destination for medical and scientific research by the end of the decade,” said Tony Wood, senior vice-president of medicinal science and technology at GSK.

“The past 18 months has shown the UK life sciences sector at its best,” he added.

More from Business

Production of the coronavirus vaccine developed by French firm Sanofi and GlaxoSmithKline (GSK) will begin within weeks, the firms have said.

The two companies are currently in Phase 3 of their trials, which will see 35,000 adult volunteers receive their coronavirus jab across the US, Asia, Africa, and Latin America.

They will test for effectiveness against the original form of COVID-19 that swept across the world after emerging in Wuhan, China, in late 2019 – and also the variant first detected in South Africa.

“Manufacturing will begin in the coming weeks to enable rapid access to the vaccine should it be approved,” a joint statement from Sanofi and GSK said.

The Sanofi-GSK vaccine could be given the green light by drugs regulators in the final three months of this year if the Phase 3 trials are successful.

 Sky News

© Sky News 2021

Written by: Rother Radio News


Previous post

UK News

Birmingham hospital cancels elective operations as NHS trusts and staff face ‘significant pressure’

A hospital in Birmingham has cancelled elective operations as other health trusts across the country face increasing pressure due to coronavirus.Pressure is mounting on hospitals and frontline medical staff as a combination of rising coronavirus cases, staff self-isolating and a backlog of other conditions threaten to overwhelm the health service. In Birmingham, elective operations at Queen Elizabeth Hospital were cancelled on Thursday and Friday due to a lack of space in intensive care contributed to by COVID.On Monday, the hospital […]

today16/07/2021